Navigation Links
Regenerative Medicine Markets - 2013 Report
Date:11/22/2013

DUBLIN, November 22, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/tntpjc/regenerative) have announced the addition of the "Regenerative Medicine Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement.

This report discusses the current state of regenerative medicine. The study provides a thorough overview of regenerative medicine sector together with analyses of the funding trends, intellectual property, market opportunities, therapeutic pipeline, research collaborations, partnership activities, and guidelines for establishing new ventures.

The report enables the reader gain in-depth knowledge about ongoing tissue engineering and stem cell therapy research programs carried out in universities and other research centers. Moreover, this analysis profiles the leading companies developing regenerative medicine solutions.

Key Topics Covered

1. Overview

2. Regenerative Medicines: An Overview of Segments

3. Regenerative Medicine: The Next Evolution of Medical Treatment

4. Recent Advances in Regenerative Medicine and Stem Cell Research

5. Stem Cell Industry Highlights, 2012

6. Regenerative Medicines: A Brief Update from Selected Countries

7. Market Analysis for Regenerative Medicine Sector

8. Stem Cell Industry

9. Business Models and Requirements for a Successful Regenerative Medicine Industry

10. Company Profiles

Examples of Companies Mentioned

  • Aastrom Biosciences
  • Altrika
  • BeFutur Biotechnologies
  • BioE
  • BioSafe Group
  • BrainStorm Cell Therapeutics
  • Cardio BioSciences
  • Cellerix
  • Cerco Medical
  • Cook Biotech
  • Cytori Therapeutics
  • Develogen
  • Forticell Bioscience
  • Gamidia Cell
  • Genzyme Corporation
  • Geron Corporation
  • Harvest Technologies Corporation
  • HemaStem Therapeutics
  • HepaLife Technologies
  • International Stem Cell Corporation (ISCO)
  • Japan Tissue Engineering
  • Kiadis Pharma
  • LifeCell
  • MaxCyte
  • NeuralStem
  • NeuroNova
  • Orthovita
  • Osiris Therapeutics
  • Pluristem Therapeutics
  • RegeneRx
  • ReNeuron Group
  • StemCells
  • Stem Cell Innovations (SCI)
  • SyntheMed
  • Tengion
  • TiGenix

Full list available at http://www.researchandmarkets.com/research/tntpjc/regenerative

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.

press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress
2. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
3. Regenerative Medicine Markets
4. Frost & Sullivan Recognizes Cytomedix for its Pioneering System that Supports the Emerging Regenerative Therapies Market
5. Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications
6. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
7. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
8. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
9. Chicago Man Breathes Again Thanks to Northwestern Medicine Study
10. Transparency Life Sciences Partners With Oncology Researchers At Icahn School Of Medicine At Mount Sinai To Assess Metformin In Prostate Cancer
11. Berg en Icahn School of Medicine van het Mount Sinai kondigen R&D- partnerschap aan voor ontdekking en ontwikkeling van geneesmiddelen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):